Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

Delayed Quote. Delayed Nasdaq - 12/19 04:14:59 pm
118.9 USD   +0.99%
5d ago VERTEX PHARMACE : David Altshuler, M.D., Ph.D., Joins Vertex as Exec..
12/08 S&P 500 MOVERS : Nbr, celg
12/08 NASDAQ 100 MOVE : Vip, celg
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on VERTEX PHARMACEUTICALS INC
2d ago VERTEX PHARMACEUTICALS : Appoints David Altshuler, M.D., Ph.D. as EVP of Global ..
3d ago VERTEX PHARMACEUTICALS : Findings on Medicinal Chemistry Reported by Investigato..
5d ago VERTEX PHARMACEUTICALS : MA : Change in Directors or Principal Officers (form 8-..
5d ago VERTEX PHARMACEUTICALS : David Altshuler, M.D., Ph.D., Joins Vertex as Executive..
12/08 S&P 500 MOVERS : Nbr, celg
12/08 NASDAQ 100 MOVERS : Vip, celg
12/03 VERTEX PHARMACEUTICALS : Patent Issued for Pyrazolopyrazine Kinase Inhibitors
12/02 U.S. Patents Awarded to Inventors in Pennsylvania (Dec. 2)
12/02 VERTEX PHARMACEUTICALS : Assigned Patent
12/01 VERTEX PHARMACEUTICALS : Alios BioPharma, Vertex Pharmaceuticals Assigned Patent
11/26 VERTEX PHARMACEUTICALS : to Present at Deutsche Bank BioFEST on December 2
11/25 VERTEX PHARMACEUTICALS : Assigned Patent
11/21 VERTEX PHARMACEUTICALS : Foundation sells $3.3B in Vertex drug royalties
11/21 NASDAQ 100 MOVERS : Vrtx, adsk
11/20 VERTEX PHARMACEUTICALS : Royalty Pharma pays $3.3 billion for CFF royalty rights..
11/20 VERTEX PHARMACEUTICALS : to Present at Deutsche Bank BioFEST on December 2
11/20 NASDAQ 100 MOVERS : Gmcr, dltr
11/19 VERTEX PHARMACEUTICALS : Studies Conducted at Vertex Pharmaceuticals Inc. on Org..
11/19 VERTEX PHARMACEUTICALS : Foundation sells $3.3B in Vertex drug royalties
11/18 VERTEX PHARMACEUTICALS : U.S. Patents Awarded to Inventors in West Virginia (Nov..
11/18 VERTEX PHARMACEUTICALS : Assigned Patent
11/12 VERTEX PHARMACEUTICALS : Submits Applications in the U.S. and Europe for Approva..
11/06 VERTEX PHARMACEUTICALS : MA Management's Discussion and Analysis of Financial Co..
11/05 VERTEX PHARMACEUTICALS : to Present at the Credit Suisse Healthcare Conference o..
11/05 VERTEX PHARMACEUTICALS : S&P 500 Analyst Moves: VRTX
11/05 VERTEX PHARMACEUTICALS : Submits Applications in the U.S. and Europe for Approva..
11/04 VERTEX PHARMACEUTICALS : Assigned Patent
10/30 VERTEX PHARMACEUTICALS : to Present at the Credit Suisse Healthcare Conference o..
10/30 VERTEX PHARMACEUTICALS : Aileron Therapeutics Expands Senior Management Team
10/29 VERTEX PHARMACEUTICALS : FDA Advisory Committee Recommends Approval of KALYDECO®..
10/29 VERTEX PHARMACEUTICALS : Patent Issued for Thiazoles, Imidazoles, and Pyrazoles ..
10/29 NASDAQ 100 MOVERS : Fb, wdc
10/28 VERTEX PHARMACEUTICALS : tops Street 3Q forecasts
10/28 VERTEX PHARMACEUTICALS : Reports Third Quarter 2014 Financial Results
10/28 VERTEX PHARMACEUTICALS : Assigned Patent
10/22 VERTEX PHARMACEUTICALS : to Announce Third Quarter 2014 Financial Results on Oct..
10/22DJU.S. HOT STOCKS : Hot Stocks to Watch
10/21 VERTEX PHARMACEUTICALS : FDA Advisory Committee Recommends Approval of KALYDECO®..
10/20 VERTEX PHARMACEUTICALS : Health and Human Services Department (HHS); Food and Dr..
10/16 AbbVie board ditches planned $55 billion Shire acquisition
10/15 VERTEX PHARMACEUTICALS : Patent Issued for Modulators of ATP-Binding Cassette Tr..
10/15 VERTEX PHARMACEUTICALS : Patent Issued for Multiwell Assay Apparatus and Method ..
10/15 VERTEX PHARMACEUTICALS : Patent Issued for Thiophene-Carboxamides Useful as Inhi..
10/14 VERTEX PHARMACEUTICALS : to Announce Third Quarter 2014 Financial Results on Oct..
10/13 Wall St. drops in late selloff; worst three days for S&P 500 since 2011
10/13 NASDAQ 100 MOVERS : Tsla, vrtx
10/13 VERTEX PHARMACEUTICALS : Health and Human Services Department (HHS); Food and Dr..
10/13 SENIOR HOUSING PROPERTIES : Vertex Pharmaceuticals Biotech Buildings Gets LEED G..
10/09 VERTEX PHARMACEUTICALS : Reviews Recent Progress and Announces Upcoming Mileston..
10/08 VERTEX PHARMACEUTICALS : Patent Issued for Solid Forms of 3-(6-(1-(2,2-Difluorob..
10/06 VERTEX PHARMACEUTICALS : Health and Human Services Department (HHS); Food and Dr..
10/03 VERTEX PHARMACEUTICALS : Research Conducted at Vertex Pharmaceuticals Inc Has Pr..
10/02 NASDAQ 100 MOVERS : Vip, myl
10/02 VERTEX PHARMACEUTICALS : Regulatory Approvals, Lawsuits, Positive Study Results,..
10/01 NASDAQ 100 MOVERS : Adp, vod
09/30 VERTEX PHARMACEUTICALS : Assigned Patent
09/24 Wall St. rallies, S&P back above 14-day moving average
09/19 NASDAQ 100 MOVERS : Mu, amzn
09/16 VERTEX PHARMACEUTICALS : Assigned Patent
09/12 NASDAQ 100 MOVERS : Vrtx, yhoo
09/11 S&P 500 rebounds with energy shares; Dow dips
09/11 VERTEX PHARMACEUTICALS : Analyst Scanner on Biotech Equities - Prana Biotechnolo..
09/10 VERTEX PHARMACEUTICALS : to Present at the Morgan Stanley Global Healthcare Conf..
09/08 VERTEX PHARMACEUTICALS : Announces Upcoming Presentations of Data at North Ameri..
09/07 VERTEX PHARMACEUTICALS : to Speak at the Morgan Stanley Global Healthcare Confer..
09/05 VERTEX PHARMACEUTICALS : S&P 500 Movers: KORS, VRTX
09/05 NASDAQ 100 MOVERS : Gild, vrtx
09/05 VERTEX PHARMACEUTICALS : to Speak at the Morgan Stanley Global Healthcare Confer..
09/04 VERTEX PHARMACEUTICALS : Researchers Submit Patent Application, "Thiophene Compo..
09/04 VERTEX PHARMACEUTICALS : Patent Issued for Processes for Producing Cycloalkylcar..
09/02 VERTEX PHARMACEUTICALS : to Present at the Morgan Stanley Global Healthcare Conf..
08/28 VERTEX PHARMACEUTICALS : Saskatchewan to cover expensive cystic fibrosis drug
08/28 NASDAQ 100 MOVERS : Vip, vrtx
08/22 VERTEX PHARMACEUTICALS : Assigned Patent
08/20 VERTEX PHARMACEUTICALS : Researchers Submit Patent Application, "Solid Forms of ..
1  2  3  4  5  6  7  8Next
Advertisement
Chart
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF